펩티드 치료제 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년 연평균 성장률(CAGR)은 11.5%로 766억 4,000만 달러로 성장합니다. 예측 기간 중의 성장은 맞춤형 의료에 대한 수요 증가, 면역 요법에서의 사용 확대, 펩티드 전달 시스템의 발전, 감염성 질환의 새로운 펩티드 표적, 희귀질환에 대한 관심 증가 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 펩티드 합성 기술 발전, 투자 및 자금 조달 확대, 펩티드 의약품의 안전성 강조, 신흥 국가 시장 확대, 인공지능(AI) 통합 등을 꼽을 수 있습니다.
펩티드 치료제 시장은 주로 만성질환의 유병률 증가로 인해 성장할 준비가 되어 있습니다. 만성질환은 장기간 지속되고 종종 완치가 불가능한 것이 특징이지만, 담배 제품 사용량 증가, 부적절한 영양 섭취, 운동 부족, 과도한 알코올 섭취 등의 요인으로 인해 증가 추세에 있습니다. 만성질환은 완치가 어렵지만 관리할 수 있고, 경우에 따라서는 통제할 수도 있습니다. 2023년 1월, 미국 국립의학도서관은 2050년까지 최소 한 가지 이상의 만성질환을 앓고 있는 50세 이상 노인의 수가 99.5% 급증하여 2050년에는 1억 4,266만 명에 달할 것이라는 미국의 심각한 예측을 발표했습니다. 발표했습니다. 이에 따라 만성질환 유병률 증가가 예상되며, 예측 기간 중 펩티드 치료제 시장의 성장을 가속하는 요인으로 작용하고 있습니다.
펩티드 치료제 시장의 성장 궤적은 노인 인구 증가에 의해 크게 영향을 받을 것으로 예상되며, 65세 이상의 노인 인구는 다양한 건강 상태의 유병률이 높습니다. 펩티드 치료제는 노화 관련 질환과 관련된 특정 경로를 표적으로 삼아 골밀도를 개선하고 골절 위험을 감소시킴으로써 이러한 질환의 관리 및 치료에 매우 중요한 역할을 하고 있으며, 2022년 10월 세계보건기구(WHO)가 발표한 세계 인구 동향에 따르면 2030년년까지 6명 중 1명이 60세 이상이 될 것이며, 2050년에는 이 연령층이 21억 명으로 두 배로 증가할 것으로 예상됩니다. 특정 지역에 미치는 영향을 더욱 강조하기 위해 영국 의회 하원 도서관은 2021년 6월 영국의 노인 인구가 증가하여 2043년까지 전체 인구의 24%(1740만 명)를 차지할 것으로 예상된다고 보고했습니다. 이러한 인구 통계학적 변화는 노인의 헬스케어 니즈에 대응하는 펩티드 치료제의 중요성이 커지고 있음을 강조하고 있습니다. 그 결과, 노인 인구 증가는 가까운 미래에 펩티드 치료제 시장의 성장을 가속하는 중요한 요인으로 부상하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, Covid, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 펩티드 치료제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
- 최종 용도 산업의 분석
- 세계의 펩티드 치료제 시장 : 성장률 분석
- 세계의 펩티드 치료제 시장 실적 : 규모와 성장, 2019-2024
- 세계의 펩티드 치료제 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 펩티드 치료제 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 펩티드 치료제 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 제네릭
- 브랜드
- 세계의 펩티드 치료제 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 비경구
- 점막
- 경구
- 경피
- 세계의 펩티드 치료제 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 암
- 심혈관질환
- 중추신경계
- 대사장애
- 감염증
- 혈액 질환
- 위장 장애
- 피부과
- 호흡기질환
- 세계의 펩티드 치료제 시장, 제네릭의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 제네릭 펩티드 의약품
- 바이오시밀러
- 세계의 펩티드 치료제 시장, 브랜드별 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 혁신적 펩티드 의약품
- 특허 보호 펩티드
제7장 지역별·국가별 분석
- 세계의 펩티드 치료제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 펩티드 치료제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 펩티드 치료제 시장 : 경쟁 구도
- 펩티드 치료제 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Jhonson & Jhonson Overview, Products and Services, Strategy and Financial Analysis
- Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- AstraZeneca plc
- Sanofi SA
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Amgen Inc.
- Novo Nordisk AS
- Teva Pharmaceuticals Industries Ltd.
- Bachem Holding AG
- PolyPeptide Laboratories BV
- Arcus Biosciences Inc.
- Pepscan Therapeutics
- Peptech Inc.
- Peptide Logic Inc.
- SELLAS Life Sciences Group
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 펩티드 치료제 시장 2029 : 새로운 기회를 제공하는 국가
- 펩티드 치료제 시장 2029 : 새로운 기회를 제공하는 부문
- 펩티드 치료제 시장 2029 : 성장 전략
제36장 부록
KSA
Peptide therapeutics involve using peptides as medicinal treatments. Peptides constitute a distinct group of pharmacological compounds positioned molecularly between proteins and small molecules. Natural peptides serve diverse roles such as hormones, growth factors, neurotransmitters, ion channel ligands, and anti-infectives. Leveraging peptides as therapies allows for targeted cell interaction and modulation of cellular responses, offering a broad spectrum of treatment possibilities.
The primary classifications of peptide therapeutics include generic and branded variants. Branded peptide therapeutics are drugs marketed under the brand names of major pharmaceutical companies that hold the patent for these medications. Branded drugs tend to be more costly than their generic counterparts, as they maintain a distinct brand identity. Peptide therapeutics can be administered through various routes such as parenteral, mucosal, oral, and transdermal. They find applications in treating a wide range of medical conditions, including cancer, cardiovascular diseases, central nervous system disorders, metabolic disorders, infections, hematological disorders, gastrointestinal disorders, dermatology issues, respiratory disorders, and acromegaly.
The peptide therapeutics market research report is one of a series of new reports from The Business Research Company that provides peptide therapeutics market statistics, including peptide therapeutics industry global market size, regional shares, competitors with a peptide therapeutics market share, detailed peptide therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the peptide therapeutics industry. This peptide therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The peptide therapeutics market size has grown rapidly in recent years. It will grow from $45.15 billion in 2024 to $49.67 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing incidence of chronic diseases, growing understanding of molecular biology, expanding applications in oncology.
The peptide therapeutics market size is expected to see rapid growth in the next few years. It will grow to $76.64 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to rising demand for personalized medicine, expanding use in immunotherapy, advancements in peptide delivery systems, emerging peptide targets in infectious diseases, increasing focus on rare diseases. Major trends in the forecast period include technological advancements in peptide synthesis, growing investment and funding, emphasis on peptide drug safety, market expansion in emerging economies, integration of artificial intelligence (AI).
The peptide therapeutics market is poised for growth, primarily fueled by the escalating prevalence of chronic diseases. Chronic diseases, characterized by their prolonged and often incurable nature, are on the rise, driven by factors such as increased tobacco product usage, suboptimal nutrition, physical inactivity, and excessive alcohol consumption. Despite being challenging to cure, chronic diseases can be managed and, in some cases, controlled. The utilization of peptide therapeutics plays a crucial role in both the prevention and treatment of certain chronic diseases. Notably, in January 2023, the National Library of Medicine, a US-based agency, reported a significant projection for the United States, indicating that the number of individuals aged 50 and older with at least one chronic condition is expected to surge by 99.5%, reaching 142.66 million by the year 2050. As a result, the anticipated increase in the prevalence of chronic diseases is set to be a key driver for the growth of the peptide therapeutics market throughout the forecast period.
The growth trajectory of the peptide therapeutics market is expected to be significantly influenced by the increasing size of the geriatric population. Defined as individuals aged 65 years and older, the geriatric population faces a higher prevalence of various health conditions. Peptide therapeutics play a pivotal role in managing and treating these conditions by targeting specific pathways associated with age-related diseases, improving bone density, and mitigating the risk of fractures. Notably, global demographic trends, as highlighted by the World Health Organization in October 2022, indicate that 1 in 6 people will be 60 years or older by 2030, with a projected doubling of this age group to 2.1 billion individuals by 2050. Further emphasizing the impact on specific regions, the UK Parliament's House of Commons Library reported in June 2021 that the senior population in the United Kingdom is expected to increase, constituting 24% of the total population (17.4 million people) by the year 2043. This demographic shift underscores the growing importance of peptide therapeutics in addressing the healthcare needs of the elderly. As a result, the rise in the geriatric population emerges as a significant driver propelling the growth of the peptide therapeutics market in the foreseeable future.
Major companies in the peptide therapeutics market are actively focused on introducing advanced solutions to gain a competitive edge, with a notable emphasis on innovations such as the cell culture process. The cell culture process involves growing cells outside of their natural environment under controlled conditions, which includes isolating cells of interest from living tissue and maintaining them. As an illustrative example, in June 2023, Evonik Industries AG, a German-based specialty chemicals company, launched cQrex KC. Positioned as a next-generation peptide for biopharma applications, cQrex KC is specifically designed for the cell culture process used in the manufacturing of biological drugs. It empowers cell culture process developers to optimize cystine supply and enhance cell culture productivity. Notably, cQrex KC contributes to the development of vaccines, viral vectors, and cell therapies, showcasing a commitment to advancing technologies that support crucial aspects of biopharmaceutical production.
Major companies in the peptide therapeutic market are strategically focused on introducing advanced solutions, with a particular emphasis on innovations such as peptide drug discovery, aiming to gain a competitive edge. Peptide drug discovery involves the process of identifying, designing, and developing therapeutic agents composed of short chains of amino acids, known as peptides. A case in point is Fujitsu Limited, a Japan-based information and communications technology equipment and services company, which, in May 2023, unveiled the Biodrug Design Accelerator. This platform is specifically designed to support peptide drug discovery scientists in pharmaceutical companies throughout the design, make, test, analyze (DMTA) cycles. Operating as a web-based solution, the Biodrug Design Accelerator provides assistance to peptide designers by offering visualization of amino acid sequences. This strategic move reflects a commitment to leveraging advanced technologies to enhance and streamline the peptide drug discovery process, ultimately contributing to advancements in therapeutic solutions.
In July 2024, AstraZeneca plc, a pharmaceutical and biotechnology company based in England, acquired Amolyt Pharma for $1.05 billion. This acquisition supports AstraZeneca's larger strategy to enhance its capabilities in rare diseases and broaden its therapeutic offerings in areas of high demand. Amolyt Pharma is a clinical-stage biotechnology company located in France, focusing on the development of therapeutic peptides designed to treat rare endocrine and metabolic disorders.
Major companies operating in the peptide therapeutics market include Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.
North America was the largest region in the peptide therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the peptide therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The peptide therapeutics market includes revenues earned by entities by creating drugs to treat a variety of diseases. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Peptide Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on peptide therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for peptide therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptide therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Generic; Branded
- 2) By Route of Administration: Parenteral; Mucosal; Oral; Transdermal
- 3) By Application: Cancer; Cardiovascular Diseases; Central Nervous Systems; Metabolic Disorders; Infections; Hematological Disorders; Gastrointestinal Disorders; Dermatology; Respiratory Disorders; Acromegaly; Other Applications
- Subsegments:
- 1) By Generic: Generic Peptide Drugs; Biosimilars
- 2) By Branded: Innovative Peptide Drugs; Patent-Protected Peptides
- Companies Mentioned: Pfizer Inc.; Jhonson & Jhonson; Abbvie Inc.; Novartis AG; Bristol-Myers Squibb Company
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Peptide Therapeutics Market Characteristics
3. Peptide Therapeutics Market Trends And Strategies
4. Peptide Therapeutics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Peptide Therapeutics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Peptide Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Peptide Therapeutics Market Growth Rate Analysis
- 5.4. Global Peptide Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Peptide Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Peptide Therapeutics Total Addressable Market (TAM)
6. Peptide Therapeutics Market Segmentation
- 6.1. Global Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Generic
- Branded
- 6.2. Global Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Parenteral
- Mucosal
- Oral
- Transdermal
- 6.3. Global Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer
- Cardiovascular Diseases
- Central Nervous Systems
- Metabolic Disorders
- Infections
- Hematological Disorders
- Gastrointestinal Disorders
- Dermatology
- Respiratory Disorders
- 6.4. Global Peptide Therapeutics Market, Sub-Segmentation Of Generic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Generic Peptide Drugs
- Biosimilars
- 6.5. Global Peptide Therapeutics Market, Sub-Segmentation Of Branded, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Innovative Peptide Drugs
- Patent-Protected Peptides
7. Peptide Therapeutics Market Regional And Country Analysis
- 7.1. Global Peptide Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Peptide Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Peptide Therapeutics Market
- 8.1. Asia-Pacific Peptide Therapeutics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Peptide Therapeutics Market
- 9.1. China Peptide Therapeutics Market Overview
- 9.2. China Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Peptide Therapeutics Market
- 10.1. India Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Peptide Therapeutics Market
- 11.1. Japan Peptide Therapeutics Market Overview
- 11.2. Japan Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Peptide Therapeutics Market
- 12.1. Australia Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Peptide Therapeutics Market
- 13.1. Indonesia Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Peptide Therapeutics Market
- 14.1. South Korea Peptide Therapeutics Market Overview
- 14.2. South Korea Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Peptide Therapeutics Market
- 15.1. Western Europe Peptide Therapeutics Market Overview
- 15.2. Western Europe Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Peptide Therapeutics Market
- 16.1. UK Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Peptide Therapeutics Market
- 17.1. Germany Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Peptide Therapeutics Market
- 18.1. France Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Peptide Therapeutics Market
- 19.1. Italy Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Peptide Therapeutics Market
- 20.1. Spain Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Peptide Therapeutics Market
- 21.1. Eastern Europe Peptide Therapeutics Market Overview
- 21.2. Eastern Europe Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Peptide Therapeutics Market
- 22.1. Russia Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Peptide Therapeutics Market
- 23.1. North America Peptide Therapeutics Market Overview
- 23.2. North America Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Peptide Therapeutics Market
- 24.1. USA Peptide Therapeutics Market Overview
- 24.2. USA Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Peptide Therapeutics Market
- 25.1. Canada Peptide Therapeutics Market Overview
- 25.2. Canada Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Peptide Therapeutics Market
- 26.1. South America Peptide Therapeutics Market Overview
- 26.2. South America Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Peptide Therapeutics Market
- 27.1. Brazil Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Peptide Therapeutics Market
- 28.1. Middle East Peptide Therapeutics Market Overview
- 28.2. Middle East Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Peptide Therapeutics Market
- 29.1. Africa Peptide Therapeutics Market Overview
- 29.2. Africa Peptide Therapeutics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Peptide Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Peptide Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Peptide Therapeutics Market Competitive Landscape And Company Profiles
- 30.1. Peptide Therapeutics Market Competitive Landscape
- 30.2. Peptide Therapeutics Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Jhonson & Jhonson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Peptide Therapeutics Market Other Major And Innovative Companies
- 31.1. AstraZeneca plc
- 31.2. Sanofi SA
- 31.3. GlaxoSmithKline plc
- 31.4. Takeda Pharmaceutical Company Limited
- 31.5. Eli Lilly and Company
- 31.6. Amgen Inc.
- 31.7. Novo Nordisk AS
- 31.8. Teva Pharmaceuticals Industries Ltd.
- 31.9. Bachem Holding AG
- 31.10. PolyPeptide Laboratories BV
- 31.11. Arcus Biosciences Inc.
- 31.12. Pepscan Therapeutics
- 31.13. Peptech Inc.
- 31.14. Peptide Logic Inc.
- 31.15. SELLAS Life Sciences Group
32. Global Peptide Therapeutics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Peptide Therapeutics Market
34. Recent Developments In The Peptide Therapeutics Market
35. Peptide Therapeutics Market High Potential Countries, Segments and Strategies
- 35.1 Peptide Therapeutics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Peptide Therapeutics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Peptide Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
